Upcoming Events › Precision Cancer Seminar

Register here >> MPCCC’s Precision Oncology Seminar series provides an educational platform in Precision Oncology covering advanced technologies for molecular profiling of tumours, molecular pathology, evidence-based classification systems for mutation actionability, molecular tumour board meetings and treatment options, all aimed at improving outcomes for cancer patients. It also provides an [...]

The use of circulating tumour DNA (ctDNA) for molecular disease monitoring has enormous potential to facilitate precision medicine and optimise cancer management across a range of malignancies. A summary of current approaches for ctDNA analysis will be presented, together with an overview of clinical applications for the use of liquid biopsies in cancer management.

Insights from cancer genome and RNA sequencing In this talk, Dr Nic Waddle will outline some of the major achievements in cancer genomics. She will then describe some of her recent work using whole genome and RNA sequencing to study cancer genomes. This will include recent work in a variety [...]

MPCCC Precision Oncology Seminars are an educational forum in which international and local guest speakers present different perspectives on the latest precision oncology research, clinical trials and treatment options. Insights into the tumour immunopeptidome and its role in personalized immunotherapy The use of mass spectrometry to characterise antigen presentation by [...]

Convergence of Public Health and Precision Oncology into Precision Public Health

Optimized 5 hydroxy-methyl seq of ctDNA as a biomarker of response in metastatic prostate cancer

“The COLUMN initiative:- Using comprehensive whole-genome & transcriptome analyses to improve diagnosis and therapeutic selection for cancers of low survival and unmet need”. The Cancer of Low Survival & Unmet Need Initiative (COLUMN) provides rapid whole genome and transcriptome analysis and is working to improve clinical diagnostics for rare, relapsed and ambiguous [...]

General and Endocrine Surgeon, The Alfred, Monash Health, Epworth Healthcare “The evolving role of molecular markers in the management of patients with thyroid cancer” Molecular markers have been playing an increasing role in the management of patients with thyroid cancer – from diagnosis, prognosis, to treatment or advanced disease. In [...]

Head, Centre for Cancer Research, Hudson Institute of Medical Research “Functional Precision Oncology: Moving Beyond Genomic Sequencing” Professor Firestein will discuss how functional interrogation of the cancer genome is being applied to repurpose existing cancer therapies and identify the next-generation of targeted therapies in both adult and paediatric malignancies. This [...]